Ayer Capital Management, LP and its managed funds are not open for investment by members of the public.
Ayer Capital Management, LP and its managed funds are not open for investment by members of the public. No offer of interests in such funds is being made or should be inferred. This web site is intended solely to provide general information about Ayer Capital Management, LP to their investors, and to financial counterparties, service providers, brokers, prospective employees, and to companies in which they invest.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 24, 2010
Cascadian Therapeutics
|
Post-IPO Equity | $14.90M | Biotechnology | — |
Ayer Capital Management has had 1 exits. Ayer Capital Management most notable exits include Cascadian Therapeutics
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Nov 29, 1991 | Cascadian Therapeutics | M&A | Biotechnology | Detail |